These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38178859)

  • 1. Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation.
    Clermont AC; Murugesan N; Edwards HJ; Lee DK; Bayliss NP; Duckworth EJ; Pethen SJ; Hampton SL; Gailani D; Feener EP
    Front Pharmacol; 2023; 14():1287487. PubMed ID: 38178859
    [No Abstract]   [Full Text] [Related]  

  • 2. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
    Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema.
    Duckworth EJ; Murugesan N; Li L; Rushbrooke LJ; Lee DK; De Donatis GM; Maetzel A; Yea CM; Hampton SL; Feener EP
    Clin Exp Allergy; 2022 Sep; 52(9):1059-1070. PubMed ID: 35278245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain.
    Ivanov I; Matafonov A; Sun MF; Mohammed BM; Cheng Q; Dickeson SK; Kundu S; Verhamme IM; Gruber A; McCrae K; Gailani D
    Blood; 2019 Mar; 133(10):1152-1163. PubMed ID: 30591525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.
    Worm M; Köhler EC; Panda R; Long A; Butler LM; Stavrou EX; Nickel KF; Fuchs TA; Renné T
    Ann Transl Med; 2015 Oct; 3(17):247. PubMed ID: 26605293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
    Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
    Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XII truncation accelerates activation in solution.
    de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
    J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Human Kinin-Forming Enzyme Inhibitors from Medicinal Herbs.
    Madkhali H; Tarawneh A; Ali Z; Le HV; Cutler SJ; Khan IA; Shariat-Madar Z
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin.
    Hintze S; Möhl BS; Beyerl J; Wulff K; Wieser A; Bork K; Meinke P
    Front Physiol; 2022; 13():1090732. PubMed ID: 36685169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative systems pharmacology model of plasma kallikrein-kinin system dysregulation in hereditary angioedema.
    Sexton D; Nguyen HQ; Juethner S; Luo H; Zhang Z; Jasper P; Zhu AZX
    J Pharmacokinet Pharmacodyn; 2024 May; ():. PubMed ID: 38734778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
    Schmaier AH
    J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XII in coagulation, inflammation and beyond.
    Didiasova M; Wujak L; Schaefer L; Wygrecka M
    Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of Factor XII-Locarno.
    Mohammed BM; Ivanov I; Matafonov A; Emsley J; Gailani D
    Res Pract Thromb Haemost; 2018 Jan; 2(1):168-173. PubMed ID: 29354798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro reconstitution of kallikrein-kinin system and progress curve analysis.
    Favier B; Bicout DJ; Baroso R; Paclet MH; Drouet C
    Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36156118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
    Bork K; Kleist R; Hardt J; Witzke G
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Plasma Kallikrein-Kininogen Pathway Is Critical in the Pathogenesis of Colitis in Mice.
    Wang B; Yang A; Zhao Z; He C; Liu Y; Colman RW; Dai J; Wu Y
    Front Immunol; 2018; 9():21. PubMed ID: 29467753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system.
    Taylor SL; Wahl-Jensen V; Copeland AM; Jahrling PB; Schmaljohn CS
    PLoS Pathog; 2013; 9(7):e1003470. PubMed ID: 23874198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-chain factor XII: a new form of activated factor XII.
    Ivanov I; Matafonov A; Gailani D
    Curr Opin Hematol; 2017 Sep; 24(5):411-418. PubMed ID: 28604413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.